Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model

Figure 7

The pathological change of infected mice lungs treated with LQ combined with oseltamivir after infection with influenza B. (a) Uninfected. (b) Treated with 75 mg/kg/day of ribavirin. (c) Placebo. (d–f) Treated with 200 mg/kg/day of LQ combined with 50/10/2 mg/kg/day of oseltamivir. (g–i) Treated with 50/10/2 mg/kg/day of oseltamivir.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)